½ÃÀ庸°í¼­
»óǰÄÚµå
1468391

¼öÀÇ ¼­ºñ½º ½ÃÀå º¸°í¼­ : ¼­ºñ½ºº°, µ¿¹° À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°(2024-2032³â)

Veterinary Service Market Report by Service (Surgery, Diagnostic Tests and Imaging, Physical Health Monitoring, and Others), Animal Type (Companion Animal, Farm Animal), End Use (Veterinary Clinic, Veterinary Hospital), and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 137 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¼öÀÇ ¼­ºñ½º ½ÃÀå ±Ô¸ð´Â 2023³â 1,131¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2032³â±îÁö ½ÃÀå ±Ô¸ð°¡ 1,700¾ï ´Þ·¯¿¡ ´ÞÇØ 2024-2032³â »çÀÌ 4.5%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

¼öÀÇ ¼­ºñ½º´Â µ¿¹° Áúº´, Àμö°øÅëÀü¿°º´, ½ÄÁßµ¶ÀÇ °¨½Ã, Á¶±â Áø´Ü ¹× Ä¡·á¿¡ Ȱ¿ëµË´Ï´Ù. µ¿¹° À¯·¡ ½ÄǰÀÇ µ¿¹°¿ë ÀǾàǰ ÀÜ·ù ¹× Ç×±ÕÁ¦ ³»¼º(AMR) ¹ß»ý°ú °ü·ÃµÈ ±ÔÁ¤ Áؼö À§¹Ý °¡´É¼ºÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ Ç×±ÕÁ¦ µî µ¿¹°¿ë ÀǾàǰ¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Äǰ »ý»êÀÚ, °¡°ø¾÷ü, À¯Åë¾÷ü¿¡ ´ëÇÑ ÀνÄÀ» Á¦°íÇÏ°í µ¿¹°¼º ½ÄǰÀÇ ¾ÈÀü¼ºÀ» È®º¸ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

¼öÀÇ ¼­ºñ½º ½ÃÀå µ¿Çâ:

µ¿¹°¿¡¼­ À¯·¡ÇÑ Àΰ£ º´¿øÃ¼ÀÇ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó µ¿¹° º¸È£, °øÁß º¸°Ç ¹× ½Äǰ ¾ÈÀü È®º¸¸¦ À§ÇØ ¼öÀÇ ¼­ºñ½º°¡ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù. ÀÌ´Â Àü ¼¼°èÀûÀ¸·Î ¹Ý·Áµ¿¹° »çÀ°ÀÌ Áõ°¡Çϰí ÀÖ´Â Ãß¼¼¿Í ÇÔ²² ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â Áß¿äÇÑ ¿äÀÎ Áß Çϳª°¡ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸¹Àº ±¹°¡ÀÇ Á¤ºÎ´Â COVID-19 »çŸ¦ ÀÌÀ¯·Î ¿ø°ÝÀÇ·á¿Í ¼öÀÇ»ç-ȯÀÚ °ü°è(VCPR)¿¡ ´ëÇÑ ±ÔÁ¦¸¦ ¿ÏÈ­ÇÏ¿© ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀÌ ¿ø°ÝÀǷḦ ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï Çã¿ëÇϰí ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á´Â ¼öÀÇÇп¡¼­ ¼ö¼ú ÈÄ Á¡°Ë, ÇǺΰúÀû ¹®Á¦, Çൿ ¹®Á¦, ¸¸¼º ÁúȯÀ» °¡Áø ¹Ý·Áµ¿¹°ÀÇ Á¤±âÀûÀÎ °æ°ú °üÂû µî¿¡ Ȱ¿ëµÇ°í ÀÖÀ¸¸ç, À̸¦ ÅëÇØ ¼öÀÇ»ç´Â ¹Ý·Áµ¿¹°À» Á÷Á¢ Áø·áÇÏÁö ¾Ê°íµµ ó¹æÀ» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ÀÌ´Â ¿Â¶óÀÎ ¹Ý·Áµ¿¹° ¾à±¹, Á¤±â ±¸¸Å ¼­ºñ½º¸¦ ÅëÇÑ »ç·á ¹× Á¦Ç° ¹è¼Û µî ÃÖ±Ù ¹Ý·Áµ¿¹° ¼­ºñ½ºÀÇ È®´ë¿Í ÇÔ²² ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î Áúº´ ºÎ´ãÀ» ÃÖ¼ÒÈ­ÇÏ°í µ¿¹°ÀÇ °Ç°­°ú º¹Áö ¼öÁØÀ» Çâ»ó½Ã۱â À§ÇÑ ¹é½Å, Ç×±ÕÁ¦, Áø´Ü µµ±¸¿Í °°Àº µ¿¹° À§»ý ¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ ¹ßÀüÀº ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ãà»ê ºÎ¹®ÀÇ °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀº ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀå¿¡ ¹àÀº Àü¸ÁÀ» °¡Á®´Ù ÁÙ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®µé

  • 2023³â ¼¼°è ¼öÀÇ ¼­ºñ½º ½ÃÀå ±Ô¸ð´Â?
  • 2024-2032³â ¼¼°è ¼öÀÇ ¼­ºñ½º ½ÃÀåÀÇ ¿¹»ó ¼ºÀå·üÀº?
  • ¼¼°è ¼öÀÇ ¼­ºñ½º ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • COVID-19°¡ ¼¼°è ¼öÀÇ ¼­ºñ½º ½ÃÀå¿¡ ¹ÌÄ£ ¿µÇâÀº?
  • ¼¼°è ¼öÀÇ ¼­ºñ½º ½ÃÀåÀÇ ¼­ºñ½ºº° ºÐ·ù´Â?
  • µ¿¹° À¯Çüº° ¼öÀÇ ¼­ºñ½º ¼¼°è ½ÃÀå ÇöȲÀº?
  • ¼¼°è ¼öÀÇ ¼­ºñ½º ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
  • ¼¼°è ¼öÀÇ ¼­ºñ½º ½ÃÀåÀÇ ÁÖ¿ä ÁøÃâ ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä »ê¾÷ µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ¼öÀÇ ¼­ºñ½º ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : ¼­ºñ½ºº°

  • ¼ö¼ú
  • ½ÃÇ衤¿µ»ó Áø´Ü
  • ½Åü °Ç°­ ¸ð´ÏÅ͸µ
  • ±âŸ

Á¦7Àå ½ÃÀå ³»¿ª : µ¿¹° À¯Çüº°

  • ¹Ý·Áµ¿¹°
  • °¡Ãà

Á¦8Àå ½ÃÀå ³»¿ª : ÃÖÁ¾ ¿ëµµº°

  • µ¿¹° º´¿ø
  • µ¿¹° Ŭ¸®´Ð

Á¦9Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ³»¿ª : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦10Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï »óȲ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Addison Biological Laboratory Inc.
    • Armor Animal Health
    • CityVet
    • CVS Group PLC
    • Elanco Animal Health Incorporated
    • Ethos Veterinary Health LLC
    • FirstVet
    • Greencross Vets
    • Heska Corporation
    • Idexx Laboratories Inc.
    • Intervet Inc.(Merck & Co. Inc.)
    • PetIQ LLC
    • Pets at Home Group PLC
ksm 24.05.13

The global veterinary service market size reached US$ 113.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 170.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032.

A veterinary service is utilized in the surveillance, early diagnosis, and treatment of animal diseases, zoonoses, and foodborne zoonotic hazards. It relies on veterinary medicinal products, such as antimicrobial agents, to minimize the likelihood of non-compliance concerning veterinary drug residues in food of animal origin and the development of antimicrobial resistance (AMR). Besides this, it assists in increasing awareness about food producers, processors and distributors, and addressing animal production food safety.

Veterinary Service Market Trends:

With the rising number of human pathogens originating in animals, veterinary services are presently becoming increasingly essential for protecting animals, safeguarding public health, and ensuring food safety. This, in confluence with the increasing adoption of companion animals around the world, represents one of the key factors stimulating the growth of the market. Moreover, governments of numerous countries are relaxing the telemedicine and veterinarian-client-patient relationship (VCPR) regulations on account of the coronavirus disease (COVID-19) outbreak and making telemedicine available to pet parents. It is utilized in veterinary for postoperative checks, dermatologic concerns, behavioral issues, and scheduled follow-up visits for pets with chronic diseases, thereby allowing veterinarians to prescribe the treatment without the direct examination of pets. This, coupled with recent expansions in pet services, including online pet pharmacies and food and product delivery via subscription services, is impelling the market growth. Apart from this, advances in animal health biotechnologies, such as vaccines, antimicrobials, and diagnostic tools, for minimizing the burden of diseases and improving the standards of animal health and welfare are positively influencing the market. In addition, significant growth in the livestock sector is projected to create a positive outlook for the market in the upcoming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global veterinary service market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on service, animal type, and end use.

Breakup by Service:

Surgery

Diagnostic Tests and Imaging

Physical Health Monitoring

Others

Breakup by Animal Type:

Companion Animal

Farm Animal

Breakup by End Use:

Veterinary Clinic

Veterinary Hospital

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Addison Biological Laboratory Inc., Armor Animal Health, CityVet, CVS Group PLC, Elanco Animal Health Incorporated, Ethos Veterinary Health LLC, FirstVet, Greencross Vets, Heska Corporation, Idexx Laboratories Inc., Intervet Inc. (Merck & Co. Inc.), PetIQ LLC and Pets at Home Group PLC.

Key Questions Answered in This Report

  • 1. What was the size of the global veterinary service market in 2023?
  • 2. What is the expected growth rate of the global veterinary service market during 2024-2032?
  • 3. What are the key factors driving the global veterinary service market?
  • 4. What has been the impact of COVID-19 on the global veterinary service market?
  • 5. What is the breakup of the global veterinary service market based on the service?
  • 6. What is the breakup of the global veterinary service market based on the animal type?
  • 7. What are the key regions in the global veterinary service market?
  • 8. Who are the key players/companies in the global veterinary service market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Veterinary Service Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Service

  • 6.1 Surgery
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Diagnostic Tests and Imaging
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Physical Health Monitoring
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Animal Type

  • 7.1 Companion Animal
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Farm Animal
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Veterinary Clinic
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Veterinary Hospital
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Addison Biological Laboratory Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Armor Animal Health
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 CityVet
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 CVS Group PLC
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Elanco Animal Health Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Ethos Veterinary Health LLC
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 FirstVet
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Greencross Vets
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Heska Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Idexx Laboratories Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Intervet Inc. (Merck & Co. Inc.)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 PetIQ LLC
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
    • 14.3.13 Pets at Home Group PLC
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦